Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 11:9:350.
doi: 10.3389/fphar.2018.00350. eCollection 2018.

Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study

Affiliations

Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study

Claudia Giardina et al. Front Pharmacol. .

Abstract

Background: Adverse drug reactions (ADRs) are an important public health problem, representing a major cause of morbidity and mortality. However, several countries have no recent studies available. Since 2014, a prospective active pharmacovigilance project, aimed to improve ADRs monitoring in hospital wards (FORWARD) was performed in Sicily. This study, as part of FORWARD project, was aimed to describe ADRs occurred during the hospital stay in Internal Medicine wards. ADRs related to hospital admission, characteristics and preventability of ADRs were also evaluated. Methods: Demographic, clinical, and pharmacological data on patients admitted to six wards of Internal Medicine, from 2014 to 2015, were collected by trained, qualified monitors, who screened all medical records. The rate of ADRs occurred during hospital stay and those leading to hospitalization were analyzed. A descriptive analysis of the reactions, suspected drugs, and associated factors was performed according to the setting analyzed. Results: During the study period, 4,802 admissions were recorded; in 3.2% of them ADRs occurred during hospital stay while in 6.2%, admission was due to ADRs. The duration of hospital stay was longer in patients who experienced ADRs during hospitalization, compared to patients without ADRs [median days 12 (Q1-Q3: 8-17) vs. 9 (6-13)]; p < 0.001). Females [OR1.39 (95% CI 1.03-1.93)] and patients taking ≥ 4 drugs [OR1.46 (95% CI 1.06-2.03)] were more likely to experience ADRs during hospital stay, as well as to be admitted because of ADRs [female: OR1.75 (95% CI 1.37-2.24); ≥ 4 drugs: OR2.14 (95% CI 1.67-2.74)]. The most frequent ADRs occurred during hospital stay were cutaneous (26.8%), general (13.4%), vascular (13.4%), and cardiac (11.5%) disorders and the drug classes mainly involved were anti-bacterials (38.2%) and antithrombotic agents (21.7%). ADRs were serious in 44.6% and probably preventable in 69.4%. Gastrointestinal (27.7%), hematological (26.5%), metabolic (18.1%), and nervous (16.1%) disorders were the main ADRs cause of hospitalization, primarily due to antithrombotic agents (39.0%) RAS-inhibitors (13.9%), NSAIDs (11.9%), and diuretics (9.0%). Only 12.9% of them was not preventable. Conclusion: Adverse drug reactions occurred during hospitalization or contributing to admission to Internal Medicine wards were considerable and most of them were preventable. Females and patients taking many medications were more likely to present ADRs both during hospital stay or as cause of admission.

Keywords: adverse drug reactions; elderly; hospital admission; internal medicine; pharmacovigilance; preventability; risk factors.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Distribution of reports of adverse drug reaction (%) by system organ classa (SOC) according to MedDRA.®
FIGURE 2
FIGURE 2
Drug classesa (ATC second level) suspected to be responsible for the reported adverse drug reactions occurring during hospital stay (A) or leading to hospitalization (B).
FIGURE 3
FIGURE 3
Distribution of ADR reports occurring during hospital stay (A) or leading to hospitalization (B) using Schumock and Thornton preventability scale.

References

    1. Al Hamid A., Ghaleb M., Aljadhey H., Aslanpour Z. (2014). A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br. J. Clin. Pharmacol. 78 202–217. 10.1111/bcp.12293 - DOI - PMC - PubMed
    1. Alacqua M., Trifiro G., Cavagna L., Caporali R., Montecucco C. M., Moretti S., et al. (2008). Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal. Arthritis Rheum. 59 568–574. 10.1002/art.23526 - DOI - PubMed
    1. Alacqua M., Trifiro G., Spina E., Moretti S., Tari D. U., Bramanti P., et al. (2009). Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005. Epilepsy Res. 85 107–113. 10.1016/j.eplepsyres.2009.03.002 - DOI - PubMed
    1. Aranaz-Andres J. M., Aibar-Remon C., Vitaller-Murillo J., Ruiz-Lopez P., Limon-Ramirez R., Terol-Garcia E., et al. (2008). Incidence of adverse events related to health care in Spain: results of the Spanish National Study of Adverse Events. J. Epidemiol. Community Health 62 1022–1029. 10.1136/jech.2007.065227 - DOI - PubMed
    1. Aronson J. K. (2013). Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring. Drug Saf. 36 147–153. 10.1007/s40264-013-0019-9 - DOI - PubMed

LinkOut - more resources